Gerry George Mathew

Scopus Publications

Reappraisal of Goal-Directed Medical Therapy in Diabetic Kidney Disease: Beyond the Quadruple Therapy Paradigm
Gerry George Mathew
Giornale Italiano Di Nefrologia Organo Ufficiale Della Societa Italiana Di Nefrologia, 2026
Diabetic kidney disease (DKD) affects 40% of individuals with diabetes and is the leading cause of chronic kidney disease worldwide. While the KDIGO guidelines have established quadruple therapy comprising renin-angiotensin system inhibitors, SGLT2 inhibitors, GLP-1 receptor agonists, and mineralocorticoid receptor antagonists as the cornerstone of DKD management, substantial phenotypic and molecular heterogeneity among patients limits the efficacy of standardized protocols. Emerging evidence highlights distinct DKD subtypes defined by inflammatory, metabolic, fibrotic, and vascular pathobiological pathways, which may warrant tailored therapeutic strategies. Novel biomarkers, including tubular injury markers, inflammatory mediators, and genetic variants such as APOL1, offer opportunities for phenotype-driven treatment. Multi-omic integration, encompassing genomics, transcriptomics, proteomics, and metabolomics, combined with machine learning algorithms, enables the identification of treatment-responsive phenotypes and supports clinical decision-making. Emerging therapeutic targets, including complement system inhibitors, ketone metabolism modulators, and JAK-STAT pathway inhibitors, have further expanded the precision medicine landscape in DKD management. Implementation challenges include biomarker standardization, healthcare infrastructure requirements, cost-effectiveness, regulatory validation, and equitable access to diverse populations. Addressing these barriers through multidisciplinary collaboration, point-of-care diagnostics, and inclusive clinical trials is essential for personalized DKD management. Goal-directed personalized DKD management represents a transformative paradigm with the potential to optimize outcomes, minimize adverse effects, and reduce long-term healthcare costs.
Twice- Versus Thrice-Weekly Hemodialysis in the Elderly: Are we ‘DLITE'd?
Gerry George Mathew
Kidney International Reports, 2026
Genotype-phenotype characteristics and disease progression of FAN1-related karyomegalic tubulointerstitial nephropathy
Michelle Clince, Elhussein A.E. Elhassan, Kendrah O. Kidd, Emily Malamud, Susan M. McAnallen, Arbab Danial, Byung Ha Chung, Myungshin Kim, John A. Sayer, Intisar Al Alawi, Jelle Bernards, Mouna Jerbi, Rym Goucha, Lamia Ben Jemaa, Imen Rejeb, Chirag Patel, Andrew J. Mallett, C. John Sperati, Koen de Boeck, Maximilian Müller, Thomas Stehlé, Nisrine Bennani Guebessi, Thomas Robert, Bela Ivanyi, Ildiko Csaszar, Shirlee Shril, Sijie Zheng, Gerry George Mathew, Merve Guzel Dirim, Ahmet Burak Dirim, Laurent Mesnard, Lorraine Gueguen, Franz Schafer, Carsten Bergmann, Daniel P. Gale, Jan Halbritter, Kathleen J. Claes, Bertrand Knebelmann, Martina Živná, Stanislav Kmoch, Stanislas Faguer, Friedhelm Hildebrandt, Anthony J. Bleyer, Peter J. Conlon
Kidney International, 2026
INTRODUCTION: Biallelic variants in Fanconi Anemia-associated Nuclease 1 (FAN1) cause karyomegalic tubulointerstitial nephropathy (KIN), a condition poorly characterized in terms of kidney survival, patient survival, and clinical characteristics. Therefore, we undertook a cross-sectional collaborative study to better characterize KIN-FAN1. METHODS: To gather data, we distributed a REDCap survey on clinical characteristics and genetic variants of KIN-FAN1 to colleagues and case report authors. RESULTS: Based on the survey, we identified 86 families affected (122 individuals) from 22 countries. There were 56 families (83 individuals) with a genetic diagnosis of KIN-FAN1, including 38 distinct FAN1 variants, and 30 families (39 individuals) with KIN with no predisposing risk factors and without molecular FAN1 testing. The median age at presentation was 38.5 years (interquartile range: 29-43), 62% male. Of the cohort, 46% had asymptomatic elevation of liver function tests, 39% had pulmonary complications, and 6% developed cancer. The median age of kidney failure was 45 years (95% confidence interval (CI): 38-56). Of the cohort, 27.1% died at a median age of 55 years (95% CI: 43-75). Pulmonary complications was/were the cause of death in 15.4% of patients on dialysis and 23.1% of kidney transplant recipients. Compared to other variants, patients with the p.W707X-FAN1 variant were at a significantly higher risk of pulmonary complications (adjusted odds ratio: 8.26 (95% CI: 1.7-40.1) and had a significantly shorter lifespan (hazard ratio: 3.24 (95% CI: 1.13-9.28). No genetic covariates were statistically associated with the progression to kidney failure. CONCLUSIONS: Patients with KIN-FAN1 develop kidney failure at a median age of 45 years. Survival is compromised with many dying of pulmonary disease.
Finrenone and sodium-glucose cotransporter 2 inhibitor polypill: how “CONFIDENT” are we?
Gerry George Mathew
Kidney Research and Clinical Practice, 2026
Interpretation of glycaemic variability in type 2 diabetes mellitus patients on maintenance haemodialysis using continuous glucose monitoring
Asokan Arunkumar, Varadharajan Jayaprakash, Rajendran Rajasekar, Rishabh Gupta, Mathew Gerry George
Nefrologia, 2026
BACKGROUND: Diabetes mellitus is the leading cause of end-stage renal disease, accounting for approximately 40% of cases. Data on glycaemic metrics in diabetic population on maintenance haemodialysis is sparse. The role of continuous glucose monitoring in this population remains underexplored. METHODS: This prospective observational study aimed to comprehensively characterize glycaemic variability using continuous glucose monitoring in patients with type 2 diabetes mellitus undergoing maintenance haemodialysis. 25 patients aged between 18 and 70 years with more than 3 months of dialysis vintage were included in the study. After collecting socio-demographic and clinical data, an ambulatory glucose profile sensor was applied to the patient's upper limb before starting their scheduled dialysis session. Sensors measured the interstitial fluid glucose every 15min, and a total of 96 readings were taken per day, continuously for 14 days (336h). RESULTS: For statistical analysis, the study population was broadly divided into 2 major groups, one which required insulin for their glycaemic management and the other requiring an oral hypoglycaemic agent, linagliptin. Statistical analysis was performed using SPSS software version 26.0 (IBM Corp., Armonk, NY). In both the groups, glycaemic excursion was observed, with dialysis days having high mean glucose values than non-dialysis days, and the observation was more prominent in the insulin-treated group. The mean glucose levels were lower in the nocturnal period in both the groups. It was noticed that the overall glycaemic variability, glycaemic variability in both dialysis and non-dialysis days were lower in linagliptin-treated group. CONCLUSION: This study demonstrated significant differences in glycaemic variability based on antidiabetic treatment modality in haemodialysis population. Continuous glucose monitoring is an invaluable tool to study glycaemic metrics and guide therapy in haemodialysis population.
The utility of eGFR difference (eGFRCystatin C – eGFRCreatinine) in the diagnosis, prognosis, and management of chronic kidney disease: a comprehensive review
Gerry George Mathew
Irish Journal of Medical Science, 2026
An observational study to assess the efficacy of ambulatory blood pressure monitoring in hypertension management among chronic kidney disease patients
Rishabh Gupta, Varadharajan Jayaprakash, Arunkumar Asokan, Gerry George Mathew
Revista Colombiana De Nefrologia, 2026
Introduction: Chronic kidney disease (CKD) poses a significant global health challenge and is often associated with hypertension (HTN) and cardiovascular diseases (CVD). Ambulatory blood pressure monitoring (ABPM) is a promising approach for precise blood pressure assessment, particularly in patients with chronic kidney disease. This study aimed to evaluate the efficacy of ABPM in managing blood pressure (BP) in patients with end-stage renal disease (ESRD) undergoing haemodialysis. Objective: This study aimed to compare the effectiveness of ambulatory blood pressure monitoring as an adjunct to routine blood pressure management in achieving optimal blood pressure control among patients on haemodialysis. The secondary objectives included a study of the variation in systolic blood pressure (SBP), diastolic blood pressure (DBP) and mean arterial pressure (MAP) at baseline and at 3 months, along with variations of night-time and daytime blood pressure in haemodialysis patients. Materials and methods: A comparative prospective study was conducted, enrolling 62 patients with chronic kidney disease undergoing haemodialysis twice weekly. ABPM was added to the routine blood pressure monitoring in the experimental group, whereas only routine blood pressure monitoring was conducted in the control group. Demographic data, pre- and post-haemodialysis blood pressure, ABPM recordings, and laboratory parameters were collected. Data analysis included descriptive statistics, t-tests, and chi-square tests. Results: The mean ages of participants in the experimental and control groups were 52 ± 16.7 years and 47.9 ± 14.3 years, respectively. The study found that ABPM significantly improved blood pressure control compared with routine monitoring at the end of 3 months. Statistically significant differences were observed in mean systolic blood pressure (140 ± 12.7 vs. 151 ± 17.6, P=0.006), diastolic blood pressure (84 ± 6.2 vs. 89 ± 8.6, P=0.011) and mean arterial pressure (106 ± 7 vs. 110 ± 8.4, P=0.046) between the two groups. Conclusion: Our study emphasizes ABPM's vital role in improving blood pressure management in CKD patients on haemodialysis and also in identifying the nuances of blood pressure variation in this vulnerable population.
Cell based therapy in chronic kidney disease: emerging evidence for a fifth pillar in guideline directed medical therapy
Gerry George Mathew
Clinical and Experimental Nephrology, 2026
Ethical Aspects and Implications of Commercialization of Renal Transplantation: A Global Perspective
Gerry George Mathew
Indian Journal of Transplantation, 2026
End-stage renal disease affects approximately 4.9 million individuals globally, with kidney transplantation providing optimal treatment outcomes. However, organ scarcity has led to commercial transplantation practices that raise significant ethical concerns. A comprehensive literature review using PubMed, EMBASE, and Cochrane databases (2010–2024), focusing on clinical outcomes, ethical frameworks, and regulatory policies regarding commercial transplantation, was conducted. Commercial transplantation accounts for 5%–10% of kidney transplants performed annually worldwide. Clinical outcomes demonstrate consistently inferior results compared to altruistic transplant systems, with higher perioperative complications (40%–65% vs. 10%–15%), increased acute rejection rates (30%–50% vs. 10%–20%), and reduced 5-year graft survival (60%–75% vs. 85%–90%). Ethical concerns include exploitation of vulnerable population, commodification of human organs, and violation of fundamental bioethical principles. Commercial renal transplantation presents complex ethical challenges requiring a comprehensive policy that address underlying organ shortage while protecting the vulnerable population and maintaining the highest clinical standards.
Spironolactone in end stage renal disease: A story of under'ACHIEVE'ment
Gerry George Mathew
Jornal Brasileiro De Nefrologia, 2026
Finerenone in CKD
Gerry George Mathew
Journal of the American Society of Nephrology, 2026
Cost-effective Approach for ABO-incompatible Renal Transplantation with High Titres
Gerry George Mathew
Indian Journal of Transplantation, 2026
Proactive Iron Versus Reactive Iron in Hemodialysis
Gerry George Mathew
Hemodialysis International, 2026
Two Sides of the Same Coin-Baclofen-Induced Intoxication in a Chronic Hemodialysis Patient
Gerry George Mathew, Arthi Sathish Rajendran, Elanthiraiyan Govindaswamy Chelvakumar
Therapeutic Apheresis and Dialysis, 2025
Unusual Cause of Headache in Lupus Nephritis
Gerry George Mathew, Elanthiraiyan Govindaswamy Chelvakumar, Anand Alwan
International Journal of Rheumatic Diseases, 2025
Role of hydroxychloroquine in primary glomerular disease - a systematic review and meta-analysis of the current evidence
Gerry George Mathew, Shanmugam Sundaramurthy, Prakash Muthuperumal, V. Jayaprakash
BMC Nephrology, 2025
Molecular markers or clinical end points? What is the optimal monitoring tool for low-dose rituximab in membranous nephropathy in resource-limited settings?
Gerry George Mathew
Journal of Nephrology, 2025
Catastrophic Allograft Thrombosis Due To Masquerading Antiphospholipid Antibodies
, Gerry George Mathew, Krishna Chaitanya Gunda, and
Turkish Journal of Nephrology, 2025
Late-onset Antibody-mediated Rejection in a Failed Allograft Masquerading as Pyrexia with Hematuria
Varadharajan Jayaprakash, Tanuj Moses Lamech, Gerry George Mathew, Senthilkumar Thiagarajan
Indian Journal of Transplantation, 2025
An abysmal conundrum associated with a misplaced dialysis catheter
Shruthi Muralidharan, Arunkumar Asokan, Nembian Raja Rajan, Gerry George Mathew, Varadharajan Jayaprakash
Journal of Vascular Access, 2025
Acrorenal Syndrome in An Elderly Male
Ilakyaa Rajakumar, Tanuj Moses Lamech, Gerry George Mathew, V Jayaprakash
Turkish Journal of Nephrology, 2025
Distal Renal Tubular Acidosis due to Sjogren's Syndrome Presenting as Quadriparesis in Pregnancy
Ilakyaa Rajakumar, Karthiga Prabhu Jayachandraprabhu, Vidhyalakshmi Ramadoss Kabilan, Udhaya Parivallal, Gerry George Mathew, Varadharajan Jayaprakash
International Journal of Rheumatic Diseases, 2025
Diffuse subcutaneous oxalosis masquerading as lower limb cellulitis
Gerry George Mathew, Anand Alwan
Kidney Research and Clinical Practice, 2025
Therapeutic efficacy of steroids in severe infection-related glomerulonephritis
Varadharajan Jayaprakash, Mathew Gerry George, Santhanam Jennie
Journal of Renal Injury Prevention, 2025
Spontaneous Colovaginal Fistula-A Rare Chronic Complication in Lupus Nephritis
Ilakyaa Rajakumar, J. Nirmal, C. D. Anand, Gerry George Mathew, V. Jayaprakash
International Journal of Rheumatic Diseases, 2025
Adult-onset Bartter syndrome type IV B with ACTH secreting pituitary microadenoma
Gerry George Mathew
Brazilian Journal of Nephrology, 2025
Linagliptin-Induced Bullous Pemphigoid in Chronic Kidney Disease
Turkish Journal of Nephrology, 2025
Autosomal Dominant Calpainopathy in a Diabetic Patient Complicated by Functional Gitelman Syndrome
Kabilash Manivalli Peterpalaniswami, Krishnaswamy Madhavan, Gerry George Mathew, V. Jayaprakash
Case Reports in Medicine, 2025
Matrix calculi in systemic lupus erythematosus complicated by distal renal tubular acidosis in a solitary kidney
Gerry G. Mathew, Varadharajan Jayaprakash
Rheumatology and Autoimmunity, 2024
A case report and literature review of IgA nephropathy presenting as nephrotic syndrome in polycythemia vera
R. Rajasekar, R. Nandakumar, Saurav P. Singhvi, Gerry George Mathew, V. Jayaprakash, K. Mythili
Cen Case Reports, 2024
Isolated postpartum central diabetes insipidus in a primi mother with postpartum preeclampsia
Gerry George Mathew, Sharmila Ganesan
Nefrologia, 2024
A rare presentation of isolated candidal hepatic abscess in a maintenance hemodialysis patient
Arunkumar Asokan, Judhajit Maiti, Gerry George Mathew, Varadharajan Jayaprakash
Hemodialysis International, 2024
Hashimoto's thyroiditis masquerading as acute tubular injury and rhabdomyolysis
Gerry George Mathew, Varadharajan Jayaprakash
Jornal Brasileiro De Nefrologia, 2024
Hashimoto’s thyroiditis masquerading as acute tubular injury and rhabdomyolysis
Gerry George Mathew, Varadharajan Jayaprakash
Brazilian Journal of Nephrology, 2024
Catheter related atrial thrombus caused by Abiotrophia defectiva: A case series and review of literature
Gerry George Mathew, Kiran Kumar Kompella, Rajamahesh Jayabalan, Venkatesh Rajkumar
Journal of Vascular Access, 2024
Prevalence and Risk Factors of Heart Failure with Preserved Ejection Fraction in Middle-Aged Maintenance Haemodialysis Patients on a Twice-Weekly Schedule: Experience from a Single Indian Centre
Gerry George Mathew, Narendhiran Pandurangan, Prakash Muthuperumal, Varadharajan Jayaprakash
Giornale Italiano Di Nefrologia, 2024
An Unusual Case of Alcoholic Liver Disease Associated with Secondary IgA Vasculitic Nephritis presenting as Rapidly Progressive Glomerulonephritis
Shruthi Muralidharan, Gerry George Mathew, Varadharajan Jayaprakash, Sreedhar Sailapathy
Giornale Italiano Di Nefrologia, 2024
Clinical implications of serum anti-PLA2R levels and glomerular PLA2R deposits in primary membranous nephropathy
Giornale Italiano Di Nefrologia Organo Ufficiale Della Societa Italiana Di Nefrologia, 2024
Immunofluorescence Negative Bullous Pemphigoid in a Hemodialysis Patient with Recurrent Ischemic Stroke
Rishabh Gupta, Gerry George Mathew, Jayaprakash Varadharajan, Sreedhar Sailapathy
Turkish Journal of Nephrology, 2024
A rare case of dialysis associated reaction presenting with urticarial vasculitis and haemoglobinuria
Varadharajan Jayaprakash, Gerry George Mathew, Suganya Muthukarupiah, Sreedhar Sailapathy, Ramachandran Ramakrishnan
Nephrology, 2024
Rectus sheath haematoma in a haemodialysis patient
Gerry George Mathew, Arunkumar Asokan, Jayaprakash Varadharajan, Sreedhar Sailapathy
BMJ Case Reports, 2024
Isolated postpartum central diabetes insipidus in a primi mother with postpartum preeclampsia
Gerry George Mathew, Sharmila Ganesan
Nefrologia, 2024
Clinical implications of serum anti-PLA2R levels and glomerular PLA2R deposits in primary membranous nephropathy
Giornale Italiano Di Nefrologia, 2024
Low-Dose Rituximab in the Treatment of Primary Membranous Nephropathy – A Systematic Review and Meta-Analysis
Gerry George Mathew, Shanmugam Sundaramurthy, Prakash Muthuperumal, Varadharajan Jayaprakash
Giornale Italiano Di Nefrologia, 2024
Rare coexistence of spinal muscular atrophy with membranous nephropathy - A clinical conundrum with management dilemma
Gerry G. Mathew, Jayaprakash Varadharajan, Sreedhar Sailapathy, R. Kalpana
Indian Journal of Pathology and Microbiology, 2024
Anti-tubercular treatment-induced granulomatous acute interstitial nephritis
Judhajit Maiti, Gerry George Mathew, V. Jayaprakash, S. Sreedhar
Indian Journal of Pharmacology, 2024
The Effect of Dialysate Temperature on Dialysis Adequacy and Hemodynamic Stability: An Experimental Study with Crossover Design
Gerry George Mathew, Suganya Muthukarupiah, Muthamizh Muniappan, Judhajit Maiti, Varadharajan Jayaprakash
Giornale Italiano Di Nefrologia, 2024
Management of a newly diagnosed case of myeloma kidney in a recently COVID-19 recovered patient
Muthukaruppaiah Suganya, Varadharajan Jayaprakash, Vasudevan Manimoliyan Duraimavalavan, Mathew Gerry George, Raghavan Padmanabhan, Sailapathy Sreedhar
Journal of Renal Injury Prevention, 2024
Lupus Nephritis, Enteritis with Cystitis Masquerading as Bilateral Hydroureteronephrosis
Gerry George Mathew, Dinesh Babu
Turkish Journal of Nephrology, 2023
Cryptococcal myositis and monoarthritis in a failed renal allograft recipient
Varadharajan Jayaprakash, Gerry George Mathew, Arunkumar Asokan, Sreedhar Sailapathy
Transplant Infectious Disease, 2023
Lentiform fork sign in continuous ambulatory peritoneal dialysis
S Muralidharan, G G Mathew, J Varadharajan, S Sailapathy, S Natarajan
QJM an International Journal of Medicine, 2023
Correlation of Acoustic Radiation Force Impulse Imaging with Chronicity Markers in Native Renal Biopsy
Giornale Italiano Di Nefrologia, 2023
Disseminated tuberculosis presenting as a crescentic glomerulonephritis
Gerry George Mathew, Dinesh Babu
Journal of Nephropathology, 2023
Case series of low dose rituximab for membranous nephropathy; a single centre experience
Gerry George Mathew, Jayaprakash Varadharajan, Sreedhar Sailapathy
Journal of Nephropathology, 2023

MOST CITED SCHOLAR PUBLICATIONS

Low-Dose Rituximab in the Treatment of Primary Membranous Nephropathy – A Systematic Review and Meta-Analysis
VJ Gerry George Mathew, Shanmugam Sundaramurthy, Prakash Muthuperumal
Giornale Italiano di nefrologia , 2024
2024
Citations: 9
Clinical implications of serum anti-PLA2R levels and glomerular PLA2R deposits in primary membranous nephropathy
KC Gunda, GG Mathew, S Balasubramanian, KSS Kumar
G Ital Nefrol 41 (2) , 2024
2024
Citations: 5
Kocuria rosea Sepsis in an Immunocompromised Patient: A Case Report
JV Shanmuga Leela A , Jaya Lakshmi S S , Leela K V , Tanuj M. Lamech ...
Cureus , 2024
2024
Citations: 3
The Effect of Dialysate Temperature on Dialysis Adequacy and Hemodynamic Stability: An Experimental Study with Crossover Design
VJ Gerry George Mathew, Suganya Muthukarupiah, Muthamizh Muniappan, Judhajit ...
Giornale Italiano di nefrologia , 2024
2024
Citations: 3
A Case Report and Literature Review of IgA Nephropathy Presenting as Nephrotic Syndrome in Polycythemia Vera
KM R.Rajasekar,R.Nandakumar,Sourav.P.Singvi,Gerry George Mathew,V.Jayaprakash
CEN Case Reports , 2024
2024
Citations: 3
The Educational Programs in Home Hemodialysis: Scoping Review
F Cicala, F Fanari, M Petralito
Giornale Italiano di Nefrologia 41 (5), 91-100 , 2024
2024
Citations: 2
Hashimoto’s thyroiditis masquerading as acute tubular injury and rhabdomyolysis
GG Mathew, V Jayaprakash
Brazilian Journal of Nephrology , 2024
2024
Citations: 2
Prevalence and Risk Factors of Heart Failure with Preserved Ejection Fraction in Middle-Aged Maintenance Haemodialysis Patients on a Twice-Weekly Schedule: Experience from a …
VJ Gerry George Mathew, Narendhiran Pandurangan, Prakash Muthuperumal
Giornale Italiano di Nefrologia 3 (41), 1-13 , 2024
2024
Citations: 2
Genotype-phenotype characteristics and disease progression of FAN1-related karyomegalic tubulointerstitial nephropathy
Kidney international , 2026
2026
Citations: 1
Role of hydroxychloroquine in primary glomerular disease - a systematic review and meta-analysis of the current evidence
PMVJ Gerry George Mathew, Shanmugam Sundaramurthy
BMC nephrology , 2025
2025
Citations: 1
Molecular markers or clinical end points? What is the optimal monitoring tool for low-dose rituximab in membranous nephropathy in resource-limited settings?
G mathew
Journal of Nephrology , 2025
2025
Citations: 1
Spontaneous Colovaginal Fistula‐A Rare Chronic Complication in Lupus Nephritis
I Rajakumar, J Nirmal, CD Anand, GG Mathew, V Jayaprakash
International Journal of Rheumatic Diseases 28 (3), e70092 , 2025
2025
Citations: 1
Therapeutic efficacy of steroids in severe infection-related glomerulonephritis
V Jayaprakash, D Jeyachandran, S Rathinam, S Sundararajan
J Renal Inj Prev 14, e32213 , 2025
2025
Citations: 1
Stenotrophomonas maltophilia in Hemodialysis: An Opportunistic Pathogen or a Malevolent Foe
TVJVLKVAAMGGV Jayaprakash
Cureus , 2024
2024
Citations: 1
The Ineffectiveness of Osimertinib in Epidermal Growth Factor Receptor (EGFR)-Mutated Stage IV Lung Adenocarcinoma With Bone Metastasis: A Case Report
CH Livingston, B Harper, M George
Cureus 16 (8) , 2024
2024
Citations: 1
An abysmal conundrum associated with a misplaced dialysis catheter
GGMVJ Shruthi Muralidharan, Arunkumar Asokan, Nembian Raja Rajan
Journal of Vascular Access , 2024
2024
Citations: 1
Correlation of Acoustic Radiation Force Impulse Imaging with Chronicity Markers in Native Renal Biopsy
KSSK Gerry George Mathew, Krishna Chaitanya Gunda, K.C. Prakash, Sudhakar ...
Giornale Italiano Di Nefrologia 4 (40) , 2023
2023
Citations: 1
Catheter related atrial thrombus caused by Abiotrophia defectiva: A case series and review of literature
VR Gerry George Mathew , Kiran Kumar Kompella, Rajamahesh Jayabalan
Journal of Vascular access , 2023
2023
Citations: 1
Lentiform fork sign in continuous ambulatory peritoneal dialysis
S Muralidharan, GG Mathew, J Varadharajan, S Sailapathy, S Natarajan
QJM: An International Journal of Medicine 116 (7), 586-587 , 2023
2023
Citations: 1
Case series of low dose rituximab for membranous nephropathy; a single centre experience
SS Gerry George Mathew, Jayaprakash Varadharajan
Journal of nephropathology 12 (DOI: 10.34172/jnp.2023.21440.) , 2023
2023
Citations: 1

Gerry George Mathew

EDUCATION

RESEARCH, TEACHING, or OTHER INTERESTS

Scopus Publications

RECENT SCHOLAR PUBLICATIONS

MOST CITED SCHOLAR PUBLICATIONS